Heidelberg Engineering Appoints New U.S. General Manager

Following the company’s relocation of its U.S. headquarters to Franklin, MA, Heidelberg Engineering Inc. is pleased to announce the appointment of Ram Liebenthal as its new U.S. General Manager. Ram is an experienced medical device executive with over 20 years of expertise in sales, marketing and innovative product commercialization with large companies such as GE Healthcare and other innovative ventures. “Under Ram’s leadership we anticipate seeing further growth in the important U.S. market, both with the introduction of new modules for the SPECTRALIS multimodal imaging platform such as the OCT Angiography Module* and with future products such as the Cataract and Refractive Imaging Platform*, and the next generation HEYEX ophthalmic image management platform*. Ram is a customer-focused, technically and commercially savvy manager very well suited for this task,” said Christoph Schoess, Managing Director of Heidelberg Engineering GmbH, parent company of Heidelberg Engineering Inc. Ram has described enhancing the customer experience as one of his top priorities. In addition, he looks forward to developing close relationships with leading ophthalmic academic and research institutions in the Boston area, which will allow the company to continue innovating with clinically relevant diagnostic imaging solutions. “Heidelberg Engineering’s strong tradition of product innovation and focus on long-term customer partnerships offer long-lasting value to customers. The HRT and the SPECTRALIS multimodal platforms are expandable, upgradable products built to last. That long-term focus paired with the ability to innovate with clinically relevant technologies make this company and its great team an organization I am proud and honored to lead,” said Ram Liebenthal, General Manager of Heidelberg Engineering Inc. *Currently under development and not for sale yet. About Heidelberg Engineering:Heidelberg Engineering is a high-tech imaging solutions company which designs, manufactures, and distributes diagnostic instruments for eye care professionals. The company’s products are used around the world by ophthalmologists and optometrists to scan patients’ eyes for signs of disease and to assist in the management of patients found to have disease. Early recognition of disease helps to delay and prevent the most common causes of blindness. Typical diseases which can be recognized and tracked with Heidelberg Engineering’s technology include glaucoma, age-related macular degeneration, diabetic retinopathy, and macular edema. The company’s core technologies include confocal microscopy, scanning lasers and optics, optical coherence tomography, software image analysis and IT solutions for image management. Heidelberg Engineering is a privately held company, headquartered in Heidelberg, Germany. The company distributes its products through a network of wholly owned subsidiaries and distribution partners in most countries of the world. www.HeidelbergEngineering.com

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.